Reminyl, Galantamine
Reminyl, Galantamine Newswire

Reminyl, Galantamine Newswire

Comprehensive Real-Time News Feed for Reminyl, Galantamine (generic).

Results 1 - 20 of 24 in Reminyl, Galantamine (generic)

  1. Cognitive remission: a novel objective for the treatment of major depression?Read the original story

    Sunday Jan 24 | CiteULike

    Cognitive dysfunction in major depressive disorder encompasses several domains, including but not limited to executive function, verbal memory, and attention. Furthermore, cognitive dysfunction is a frequent residual manifestation in depression and may persist during the remitted phase.

    Comment?

  2. Alzheimer's prescriptions 'six times higher than in 2004'The number...Read the original story w/Photo

    Tuesday Jan 19 | This is The West Country

    The number of prescriptions for drugs to treat Alzheimer's disease is now six times higher than a decade ago. There has been a Government drive to encourage doctors to diagnose cases of dementia, with GPs receiving payments to boost the numbers.

    Comment?

  3. Cholinergic stimulation enhances Bayesian belief updating in the deployment of spatial attention.Read the original story

    Dec 6, 2015 | CiteULike

    The Journal of neuroscience : the official journal of the Society for Neuroscience , Vol. 34, No.

    Comment?

  4. Canadian Medical Association Journal publishes CTFPHC's...Read the original story

    Nov 30, 2015 | Sys-Con Media

    These recommendations were published today in the Canadian Medical Association Journal . Cognitive impairment occurs along a continuum from mild cognitive impairment , characterized by memory complaints occurring as part of the normal aging process, to more severe memory and cognitive deficits occurring as a result of dementia, which impede daily functioning.

    Comment?

  5. Memantine treatment in patients with mild to moderate Alzheimer's...Read the original story

    Nov 28, 2015 | CiteULike

    Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: a randomized, double-blind, placebo-controlled trial. To evaluate the efficacy and safety of memantine in patients with mild to moderate Alzheimer's disease receiving cholinesterase inhibitor treatment.

    Comment?

  6. Dementia treatments less likely to be prescribed in poorer areas of EnglandRead the original story

    Nov 19, 2015 | PressReleasePoint

    A UK study has found that people with dementia who live in more deprived areas of England are less likely to be prescribed anti-dementia treatments than those in wealthier areas. The study, which also shows that these inequalities in England are not replicated in other parts of the UK, is published in the journal Age and Ageing .

    Comment?

  7. Medicine Used To Treat ADHD May Help Patients With Post-Traumatic Stress DisorderRead the original story

    Nov 5, 2015 | WBIW-AM Bedford

    A drug used to treat attention deficit hyperactivity disorder may be a significantly better treatment alternative for post-traumatic stress disorder than current therapies, according to new research. Scientists at the Indiana University School of Medicine, Spaulding Rehabilitation Hospital/ Harvard Medical School and the University of California, San Diego, announced the results of human tests of the ADHD drug, as well as a second drug that is approved for Alzheimer's disease treatment, in a report published online by the journal Neuropsychopharmacology.

    Comment?

  8. Medicine used to treat ADHD may also help patients with post-traumatic stress disorderRead the original story w/Photo

    Nov 5, 2015 | Medical News Today

    A drug used to treat attention deficit hyperactivity disorder may be a significantly better treatment alternative for post-traumatic stress disorder than current therapies, according to new research. Scientists at the Indiana University School of Medicine, Spaulding Rehabilitation Hospital/ Harvard Medical School and the University of California, San Diego, announced the results of human tests of the ADHD drug, as well as a second drug that is approved for Alzheimer's disease treatment, in a report published online by the journal Neuropsychopharmacology .

    Comment?

  9. Gateway to InfinityRead the original story w/Photo

    Sep 3, 2015 | The Huffington Post

    Dreaming has long been considered a gateway to the infinite. The ancient Greeks believed dreams predicted the future.

    Comment?

  10. Much ado about cognitive declineRead the original story

    Aug 25, 2015 | Times Beacon Record

    I think most of us can agree that we want to age as gracefully as possible. But, what does this mean? While we may want to avoid physical ailments, such as achy joints and musculoskeletal pain, cognitive decline seems to be one of the scarier prospects as we age.

    Comment?

  11. Positive allosteric modulation of alpha 7 nicotinic acetylcholine...Read the original story

    Aug 23, 2015 | CiteULike

    A wide body of preclinical and clinical data suggests that alpha 7 nicotinic acetylcholine receptors may represent useful targets for cognitive improvement in schizophrenia and Alzheimer 3s disease. A promising recent approach is based on the use of positive allosteric modulators of I 7-nAChRs due to their several advantages over the direct agonists.

    Comment?

  12. Current Practices in the Treatment of Alzheimer Disease: Where is the ...Read the original story

    Aug 18, 2015 | CiteULike

    The purpose of this systematic review was to review the current place in therapy of the 4 medications, donepezil, rivastigmine, galantamine, and memantine, approved for the treatment of Alzheimer disease since the publication of Phase III trials. A systematic literature search of MEDLINE and EMBASE was conducted for articles published in the past 10 years.

    Comment?

  13. Testing for early signs of Alzheimer just got easierRead the original story w/Photo

    Aug 11, 2015 | Examiner.com

    Patients will soon be able to conduct a simple test to determine whether they are suffering from early onset Alzheimer's while their physicians are busy with other patients, using a cognitive assessment tool called Conivue that works something like a video game. According to inventor, Charles Duffy, a neurology professor at the University of Rochester, NY, the device can detect subtle lapses in the perceptual ability of the brain that may signal the early development of the disease in as little as 10-minutes.

    Comment?

  14. Dementia Meds Tied to Harmful Weight LossRead the original story w/Photo

    Aug 3, 2015 | News Max

    Common dementia medications can cause harmful weight loss in some patients, new research shows. The findings, by University of California-San Francisco scientists, underscore the need for clinicians take into account for the risks - as well as the potential benefits - of prescribing such drugs to older adults.

    Comment?

  15. Common Dementia Drugs Might Do More Harm Than GoodRead the original story w/Photo

    Aug 3, 2015 | MSN Healthy Living

    Researchers from the University of California-San Francisco are finding that commonly prescribed dementia medications can lead to dangerous weight loss in patients . In light of this new evidence, they are cautioning physicians to be careful when prescribing medication to their patients.

    Comment?

  16. Common medications for dementia could cause harmful weight lossRead the original story w/Photo

    Aug 3, 2015 | PhysOrg Weblog

    Medications commonly used to treat dementia could result in harmful weight loss, according to UC San Francisco researchers, and clinicians need to account for this risk when prescribing these drugs to older adults, they said. "This is very relevant to patient care because unintentional weight loss in older adults is associated with many adverse outcomes, including increased rates of institutionalization and mortality, a decline in functional status, and poorer quality of life," said lead author Meera Sheffrin, MD, geriatrics fellow in the UCSF School of Medicine at the UCSF-affiliated San Francisco VA Medical Center.

    Comment?

  17. Common Dementia And Alzheimer's Medications May Cause...Read the original story w/Photo

    Aug 3, 2015 | Medical Daily

    Researchers from the University of California-San Francisco are finding that commonly prescribed dementia medications can lead to dangerous weight loss in patients . In light of this new evidence, they are cautioning physicians to be careful when prescribing medication to their patients.

    Comment?

  18. Positive allosteric modulators of alpha 7 nicotinic acetylcholine...Read the original story

    Aug 2, 2015 | CiteULike

    To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document. Alpha 7 nicotinic acetylcholine receptors have generated great interest as targets of new pharmacological treatments for cognitive dysfunction in schizophrenia.

    Comment?

  19. Dream Hacking: Understanding Everyday Behaviors That Impact Your DreamsRead the original story w/Photo

    Jul 24, 2015 | The Huffington Post

    No, we aren't talking about Inception or the latest sci-fi thriller; what you do while awake actually can influence your dreams and how you sleep! However, newer research shows that some behaviors can actually affect your dreams in both good and bad ways. Learn what habits and daytime activities might be influencing your rest, and see how to hack your dreams.

    Comment?

  20. New Alzheimer's drug could slow decline: expertsRead the original story w/Photo

    Jul 22, 2015 | ABC News

    "In other words, for individual patients... they don't get better than they were when they started the drug but it slows the rate of decline." Eli Lilly said patients with mild Alzheimer's disease who took the experimental drug early in the course of their disease preserved more of their cognitive and functional ability.

    Comment?